2-[4-[(4,4-difluorocyclohexyl)amino]-2-(3,5-dimethylpyrazol-1-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]acetonitrile;N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-amine
C38H49F4N13 — CID 159319897
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[(4,4-difluorocyclohexyl)amino]-2-(3,5-dimethylpyrazol-1-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]acetonitrile;N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-amine
2-[4-[(4,4-difluorocyclohexyl)amino]-2-(3,5-dimethylpyrazol-1-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]acetonitrile;N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-amine (PubChem CID 159319897) has the molecular formula C38H49F4N13 and a molecular weight of 763.89 g/mol. Its IUPAC name is 2-[4-[(4,4-difluorocyclohexyl)amino]-2-(3,5-dimethylpyrazol-1-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]acetonitrile;N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-amine.
Molecular Properties
| Compound Name | 2-[4-[(4,4-difluorocyclohexyl)amino]-2-(3,5-dimethylpyrazol-1-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]acetonitrile;N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-amine |
|---|---|
| PubChem CID | 159319897 |
| Molecular Formula | C38H49F4N13 |
| Molecular Weight | 763.89 g/mol |
| Exact Mass | 763.42 |
| IUPAC Name | 2-[4-[(4,4-difluorocyclohexyl)amino]-2-(3,5-dimethylpyrazol-1-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]acetonitrile;N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-amine |
| SMILES | Cc1cc(C)n(-c2nc3c(c(NC4CCC(F)(F)CC4)n2)CCN(CC#N)C3)n1.Cc1cc(C)n(-c2nc3c(c(NC4CCC(F)(F)CC4)n2)CCNC3)n1 |
| InChI | InChI=1S/C20H25F2N7.C18H24F2N6/c1-13-11-14(2)29(27-13)19-25-17-12-28(10-8-23)9-5-16(17)18(26-19)24-15-3-6-20(21,22)7-4-15;1-11-9-12(2)26(25-11)17-23-15-10-21-8-5-14(15)16(24-17)22-13-3-6-18(19,20)7-4-13/h11,15H,3-7,9-10,12H2,1-2H3,(H,24,25,26);9,13,21H,3-8,10H2,1-2H3,(H,22,23,24) |
| InChIKey | LDPXZPUDTRLACG-UHFFFAOYSA-N |
| XLogP | 6.07 |
| TPSA | 150.32 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 55 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 763.89 |
| LogP ≤ 5 | 6.07 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 13 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'cyanamide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159319897 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.